Valuation : Simcere Pharmaceutical Group Limited

Market Cap 3.7B 29.02B 3.19B 2.99B 2.73B 5.14B 354B 5.16B 35.48B 13.84B 179B 13.9B 13.59B 592B P/E 2026 *
14.1x
P/E 2027 * 12.3x
Enterprise Value 3.5B 27.47B 3.02B 2.83B 2.58B 4.87B 335B 4.88B 33.59B 13.11B 169B 13.16B 12.87B 561B EV / Sales 2026 *
2.33x
EV / Sales 2027 * 2.11x
Free-Float
32.13%
Yield 2026 *
3.72%
Yield 2027 * 4.22%
1 day-1.77%
1 week-4.31%
Current month-10.12%
1 month-10.12%
3 months+10.01%
6 months-3.98%
Current year-7.27%
1 week 11.02
Extreme 11.02
11.79
1 month 11.02
Extreme 11.02
12.82
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.55
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 19/08/2026
Chief Executive Officer 54 24/03/2026
Director of Finance/CFO 55 18/11/2019
Director TitleAgeSince
Chairman 63 07/10/2012
Director/Board Member 55 18/11/2019
Director/Board Member 46 31/10/2019
Date Insider Type Main position Quantity % Market Cap.
20/08/26 Other

Chairperson

-3,000,000 0.1168%
13/07/26 Other

Founder

-47,000 0.0018%
13/07/26 Other

Director

-47,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
-1.77%-4.31%-21.16%+81.67% 3.7B
+3.38%+3.92%+26.96%+78.55% 48.2B
+0.66%+0.33%+54.40%+120.88% 39.97B
-2.49%+5.21%+17.18%+85.56% 12.43B
-1.00%-2.00%-11.21%+12.05% 12.03B
+0.19%0.00%+29.35%+150.00% 9.35B
-1.50%-1.28%+25.69%+49.12% 7.75B
-1.39%+3.74%+28.71%+223.40% 7.43B
-0.26%+0.27%+43.89%-11.26% 7.22B
-0.53%-1.53%-36.09%+17.02% 5.3B
Average -0.48%+1.44%+15.77%+80.70% 15.34B
Weighted average by Cap. +0.75%+1.23%+27.95%+88.54%

Financials

2026 *2027 *
Net sales 1.5B 11.77B 1.29B 1.21B 1.11B 2.09B 143B 2.09B 14.39B 5.61B 72.43B 5.64B 5.51B 240B 1.69B 13.27B 1.46B 1.37B 1.25B 2.35B 162B 2.36B 16.22B 6.33B 81.63B 6.35B 6.21B 271B
Net income 255M 2B 220M 206M 188M 355M 24.4B 356M 2.45B 955M 12.31B 958M 937M 40.83B 302M 2.37B 260M 244M 222M 419M 28.83B 420M 2.89B 1.13B 14.55B 1.13B 1.11B 48.26B
Net Debt -197M -1.55B -170M -159M -146M -274M -18.86B -275M -1.89B -738M -9.52B -741M -725M -31.56B -140M -1.1B -120M -113M -103M -194M -13.36B -195M -1.34B -523M -6.74B -525M -513M -22.36B
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
7,064
Date Price Change Volume
31/08/26 HK$11.10 -1.77% 7,703,000
28/08/26 HK$11.30 -1.82% 4,726,000
27/08/26 HK$11.51 -0.78% 4,617,000
26/08/26 HK$11.60 +0.61% 5,882,000
25/08/26 HK$11.53 -0.60% 5,952,643
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.697CNY
Average target price
15.11CNY
Spread / Average Target
+55.84%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2096 Stock